Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04834544 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care

StatusRecruiting
PhasePhase 2
Started2021-04-19
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 3, 2021 (before its estimated October 20, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2021-04-30
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-04-20→confirmed 2021-04-19
Study sitesdetails revised at 1 of 1 site
2021-04-13
Recruiting→Not Yet Recruiting Study Identification, Study Status, Study Description, Contacts/Locations v1
Trial statusRecruiting→Not Yet Recruiting
Primary completion date2023-03-20→2024-10-20
Completion date2025-03-20→2027-04-20
Start date2021-03-23→2021-04-20
Study sitesdetails revised at 1 of 1 site
2021-04-06
Original filing
This is a randomized, double-blind, placebo-controlled,parallel-group preliminary verifying study about safety and efficacy of maintenance DCVAC/OvCa after first-line chemotherapy added to standard of care in patients with newly diagnosed FIGO III-IV ovarian, fallopian tube, or primary peritoneal carcinoma.
Trial Details
NCT Number NCT04834544
Lead Sponsor Peking University Third Hospital
Collaborators: SOTIO a.s.
Conditions Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma
Enrollment 75 participants
Start Date 2021-04-19
Primary Completion 2024-10-20 (estimated)
Study Completion 2027-04-20 (estimated)
Updated on ClinicalTrials.gov 2021-05-03